Navigation Links
Paragon Quadra RG (paflufocon B)

ProductsParagon Quadra RG (paflufocon B)
Company Paragon Vision Sciences
Item Paragon Quadra RG (paflufocon B)
Features CRT has been made possible by five new technologies:
  • Advances in multicurve GP lenses specifically designed to facilitate the safe redistribution of corneal tissue while sleeping.
  • Advances in computer controlled lathing technology, allowing complex lens designs to be consistently fabricated and, in the case of Paragon CRT, with seamless, polishless surfaces and on a tolerance level measured in microns.
  • The development of stable, wettable, high Dk materials that can be safely worn overnight.
  • Advances in computerized corneal mapping techniques providing more precise fitting and follow-up patients.
  • A greater understanding of how corneal reshaping works and the tissues involved in the process.
Description These are rigid gas permeable contact lenses used for corneal refractive therapy, a process that temporarily corrects nearsightedness (myopia). The patient wears the lenses overnight while sleeping and removes them upon wakening. During the day, nearsightedness is corrected or greatly reduced

The Paragon CRT and Quadra RG contact lenses apply slight pressure to the center of the cornea, causing it to temporarily flatten. The flattened cornea redirects light onto the back surface of the eye (the retina) at an angle that can compensate for nearsightedness. Since the cornea is elastic, it gradually regains its shape throughout the day (causing nearsightedness to return). Usually, patients must wear the lenses every night to maintain corrected vision.

The lenses are used for the temporary correction of nearsightedness. They can be used by patients with or without vision distortion (astigmatism). They are usually worn overnight as part of a corneal refractive therapy program. When the lenses are removed each morning, they must be cleaned using a chemical disinfection system.

Why Paragon CRT is the right choice for your practice:

  • Paragon CRT brings opportunity for your practice growth and patient retention.
  • Take advantage! Refractive surgery has created a market of patients wanting freedom from glasses and daytime contacts without surgery.
  • Paragon CRT sets the standard for Corneal Refractive Therapy not only with the first FDA approval for overnight CRT but also by offering a Total System which includes a Diagnostic Dispensing System and a Complete Practice Management Program.
  • With no age restrictions, Paragon CRT is the perfect option for active kids and teens who arent eligible for refractive surgery.
  • Paragon CRT rounds out your practice and is the perfect complement for refractive surgery and 30-day continuous wear lenses.
Info Paragon Vision Sciences
Customer Service: (800) 528-8279
Web site: http://www.paragonvision.com

Related medicine products :

1. Paragon CRT 100 (paflufocon D)
2. Paragon CRT (paflufocon B)
3. Paragon Quadra RG 100 (paflufocon D)
4. Paragon CZE 2000 Capillary Electrophoresis System
5. Paragon™ Nitinol Paired Helical Basket
6. Paragonimiasis Antibody
7. Webster Quadrapolar Standard Deflectable Catheters
8. Quadra-Coil® Multi-Length Ureteral Stents
9. QuadraLase™
... monoclonal antibody based colorimetric test intended ... gonorrhoeae. The test requires less than ... heating or pretreatment. The test does ... cultures. GonoGen&trade II eliminates agglutination, guesswork, ...
... a monoclonal antibody based coagglutination ... identification of Neisseria gonorrhoeae. The ... viable or fresh cultures. After ... minute rotation, a positive reaction ...
Rapid Test Kit...
... The InTray™ GC is a ... detection of both Neisseria gonorrhoeae and ... a long shelf life and is ... system. Simply inoculate, incubate and ...
Medicine Products:
(Date:6/27/2016)... ... 27, 2016 , ... The OSHA Training Center at ... Center headquartered in Northern California, has issued an important reminder to employers to ... Employers with workers exposed to high temperatures should establish a complete heat ...
(Date:6/27/2016)... ... ... "FCPX editors can now reveal their media with growing colorful split screen ... - CEO of Pixel Film Studios. , ProSlice Color brings the split screens ... reveal the media of their split screens with growing colorful panels. , ProSlice Color ...
(Date:6/27/2016)... (PRWEB) , ... June 27, 2016 , ... ... for mental health professionals, announced today its affiliation with Tennessee Counseling Association. ... solutions to the network of the Tennessee Counseling Association, adding exclusive benefits and ...
(Date:6/27/2016)... ... June 27, 2016 , ... ... industry today announced its strategic partnership with Connance, a healthcare industry leader ... two companies’ proven, proprietary technology combine to provide health systems, hospitals and ...
(Date:6/27/2016)... ... June 27, 2016 , ... A revolution ... the emergency ambulance transport experience for the millions of people who require these ... disrupted the taxi industry through the use of technology. Now, SmartEMS has put ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... One of Australia,s successful biotechnology scientists, Dr ... biotechnology company, Noxopharm Limited [ABN 50 608 966 123] ("Noxopharm"). Noxopharm ... on the ASX. Noxopharm is a clinic-ready company with ... 1 clinical study later this year. ... problems facing cancer patients - the ability of cancers to become ...
(Date:6/26/2016)... , June 27, 2016 Jazz Pharmaceuticals ... waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of ... acquisition of Celator Pharmaceuticals, Inc. ("Celator"; Nasdaq: ... p.m. (Eastern Daylight Time). As previously announced ... into a definitive merger agreement under which Jazz Pharmaceuticals ...
(Date:6/26/2016)... OTTAWA, Ontario , June 27, 2016  VMS ... the Company,s Board will take whatever measures required to ... the Company,s stock which is currently listed on the ... S Wexler, Company Chairman and CEO, "We are seeing ... be difficult to understand, not only by the Company, ...
Breaking Medicine Technology: